GSK’s new asthma drug Relvar Ellipta has shown itself ... Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its ...

The precise mechanism through which fluticasone furoate affects COPD and asthma symptoms is not known. Corticosteroids have been shown to have a wide range of actions on multiple cell types (eg ...

Trilogy Ellipta and Breo Ellipta are both prescribed to treat certain breathing problems in adults, such as chronic obstructive pulmonary disease and asthma. To find out the cost of Trelegy ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive ... followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the parent ...

Sales of its asthma and COPD medication Advair are declining, and payers are demanding more from its next generation treatments Breo and Anoro Ellipta. “Digital innovations, like sensor ...